Discovery On Target 2012

Discovery on Target 2012 a Great Success;
Draws Record Attendance
 


Mark your calendar for 2013! 


Discovery on Target 2013 will be held September 24-26 at the Westin Boston Waterfront in Boston, MA. 

Discovery on Target 2012 would like to thank all speakers, attendees, sponsors, and exhibitors who came to Boston for the 10th anniversary. The event drew a large number of attendees with 630+ participants from 24 countries networking and discussing the latest topics and events within novel drug targets.

We will soon begin working on the program for 2013. If you are interested in speaking, please contact Margit Eder, Ph.D., Conference Director at meder@healthtech.com.

To customize your sponsorship or exhibit package for 2013, contact Jon Stroup, Business Development Manager at jstroup@healthtech.com. The exhibit hall was sold out in 2012, so please contact us early to reserve your place.

View 2012 Media Gallery 

Scientific Programs
October 1-2
October 2-3

GPCR


 
 

Arrow DownCONFERENCE-AT-A-GLANCE

Arrow DownDOWNLOAD 2015 BROCHURE

Arrow Overshort courses

Arrow OverVIEW ALL SPONSORS

Arrow OverVIEW MEDIA PARTNERS


SPONSORSHIPS & EXHIBITS

The exhibit hall was sold out in 2015, so please contact us early to reserve your place. To customize your sponsorship or exhibit package for 2016, contact:

Jon Stroup
Sr. Business Development Manager
781-972-5483
jstroup@healthtech.com

 

DOT-Vid-recap

2015 Tracks

September 21

Next-Generation Histone Deacetylase Inhibitors Symposia

Strategies for Rare Diseases Symposia

September 22

Developing CRISPR-Based Therapies Symposia

September 22 - 23

Targeting Epigenetic Readers and Chromatin Remodelers

Targeting the Ubiquitin Proteasome System

Targeting the Microbiome

GPCR - Based Drug Discovery - Part 1

Antibodies Against Membrane Protein Targets - Part 1

RNAi for Functional Genomics Screening

Gene Therapy Breakthroughs

Targeting Ocular Disorders

September 23 - 24

Targeting Histone Methyltransferases and Demethylases

Targeting the Unfolded Protein Response

Kinase Inhibitor Discovery

GPCR-Based Drug Discovery - Part 2

Antibodies Against Membrane Protein Targets - Part 2

New Frontiers in Gene Editing

Quantitative Systems Pharmacology

2015 Short Courses

SC1: Cancer Metabolism: Pathways, Targets and Clinical Updates

SC2: Leveraging Data and Analytics for Drug DiSCovery

SC3: Setting Up Effective Rnai SCreens: From Design to Data to Validation

SC4: Phenotypic SCreening and Chemical Probe Development

SC5: GPCR Structure-based Drug Discovery

SC6: Targeting of GPCRs with Monoclonal Antibodies

SC7: Setting Up Effective Functional SCreens Using 3D Cell Cultures

SC8: Targeting Protein-protein Interactions: Biophysical Approaches

SC9: Preclinical Animal Models for Ocular Indications

SC10: Introduction to Allosteric Modulators and Biased Ligands of GPCRs

SC11: Introduction to Targeted Covalent Inhibitors

SC12: Assays and High-throughput SCreening for Novel Epigenetic Inhibitors

SC13: Gamification and Drug Target Challenges

SC14: A Primer to Gene Editing: Tools and Applications

SC15: Using Mechanistic Physiological Models In Drug Development